Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 9Breast Neoplasms 7Neoplasms 5Colorectal Neoplasms 5Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 3Triple Negative Breast Neoplasms 2Sarcoma 2Pancreatic Neoplasms 2Melanoma 2Hematopoietic and Lymphatic System Neoplasm 2Hematologic Neoplasms 2Depression 2Anxiety Disorders 2Alzheimer Disease 2Advanced Malignant Solid Neoplasm 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Tobacco Smoking 1Testicular Neoplasms 1Spondylitis, Ankylosing 1Specific Learning Disorder 1Smoking Cessation 1Smoking 1Signs and Symptoms 1Sedentary Behavior 1Rectal Neoplasms 1Psoriasis 1Pancreatic Diseases 1Pancreatic Cyst 1

Interventions

Nicotine Replacement Therapy 2Urinalysis 1Tobacco Use Cessation Devices 1Therapeutics 1Telemedicine 1Smoking Devices 1Nicotine Chewing Gum 1Music Therapy 1Mindfulness 1Methods 1Ethanol 1Amyloid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Smoking Cessation × Methods × Clear all
NCT06945120 2026-03-13

ACT Lung Health Intervention: Phase Two

Dana-Farber Cancer Institute

Phase NA Recruiting
50 enrolled

Cigarette Smoking, Tobacco Smoking, Smoking, Smoking Cessation, Behavior, Addictive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡